The global market for Polymyxin B was valued at US$ 620 million in the year 2024 and is projected to reach a revised size of US$ 849 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Polymyxin B Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polymyxin B competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Polymyxin B production reached approximately 3.76 thousand tons, with an average global market price of around US$ 165,000 per ton. The gross profit margin of major producers ranges from 35% to 55%. Single-line production capacity typically ranges from 120 to 380 tons per year, depending on fermentation scale, purification capability, and bioreactor efficiency.

Polymyxin B is a peptide-based antibiotic derived from Paenibacillus polymyxa and is known for strong activity against multidrug-resistant Gram-negative bacteria. It is widely used as a last-line therapy for severe infections caused by Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Due to its narrow therapeutic window, its API production requires high-purity fermentation, complex extraction, and strict quality control.

The industrial chain includes upstream suppliers of fermentation media, amino acids, peptide precursors, bioreactor components, and pharmaceutical-grade solvents. Midstream manufacturers conduct microbial fermentation, extraction, chromatography purification, lyophilization, and sterile API packaging. Downstream users include injectable-drug manufacturers, hospital pharmacy networks, critical-care units, and anti-infective treatment centers.

North American market for Polymyxin B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Polymyxin B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Polymyxin B include Pfizer, Zhejiang Hisun Pharmaceutical, Xellia Pharmaceuticals, Cipla, Lupin, B. Braun, Shanghai Pharmaceutical, Novartis Sandoz, Alkem Labs, Par Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polymyxin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxin B.

The Polymyxin B market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymyxin B market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polymyxin B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Source and by regions.

Scope of Polymyxin B Market Report

Report Metric	Details
Report Name	Polymyxin B Market
Accounted market size in year	US$ 620 million
Forecasted market size in 2031	US$ 849 million
CAGR	4.6%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Injection Polymyxins Oral Polymyxins Topical Polymyxins
Segment by Source	Natural Fermentation Polymyxin B Semi-Synthetic Polymyxin B Purified Fermentation Polymyxin B
Segment by Application	Intestinal Disease Infection Septicemia Peritonitis Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Zhejiang Hisun Pharmaceutical, Xellia Pharmaceuticals, Cipla, Lupin, B. Braun, Shanghai Pharmaceutical, Novartis Sandoz, Alkem Labs, Par Pharmaceutical, Gland Pharma, Hikma, Merck, Fresenius Kabi, Hanmi Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxin B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxin B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Polymyxin B Market growing?

Ans: The Polymyxin B Market witnessing a CAGR of 4.6% during the forecast period 2026-2031.

What is the Polymyxin B Market size in 2031?

Ans: The Polymyxin B Market size in 2031 will be US$ 849 million.

Who are the main players in the Polymyxin B Market report?

Ans: The main players in the Polymyxin B Market are Pfizer, Zhejiang Hisun Pharmaceutical, Xellia Pharmaceuticals, Cipla, Lupin, B. Braun, Shanghai Pharmaceutical, Novartis Sandoz, Alkem Labs, Par Pharmaceutical, Gland Pharma, Hikma, Merck, Fresenius Kabi, Hanmi Pharma

What are the Application segmentation covered in the Polymyxin B Market report?

Ans: The Applications covered in the Polymyxin B Market report are Intestinal Disease, Infection, Septicemia, Peritonitis, Others

What are the Type segmentation covered in the Polymyxin B Market report?

Ans: The Types covered in the Polymyxin B Market report are Injection Polymyxins, Oral Polymyxins, Topical Polymyxins

1 Polymyxin B Market Overview

1.1 Product Definition

1.2 Polymyxin B by Type

1.2.1 Global Polymyxin B Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injection Polymyxins

1.2.3 Oral Polymyxins

1.2.4 Topical Polymyxins

1.3 Polymyxin B by Source

1.3.1 Global Polymyxin B Market Value Comparison by Source: 2024 VS 2031

1.3.2 Natural Fermentation Polymyxin B

1.3.3 Semi-Synthetic Polymyxin B

1.3.4 Purified Fermentation Polymyxin B

1.4 Polymyxin B by Application

1.4.1 Global Polymyxin B Market Value by Application (2024 VS 2031)

1.4.2 Intestinal Disease

1.4.3 Infection

1.4.4 Septicemia

1.4.5 Peritonitis

1.4.6 Others

1.5 Global Polymyxin B Market Size Estimates and Forecasts

1.5.1 Global Polymyxin B Revenue 2020-2031

1.5.2 Global Polymyxin B Sales 2020-2031

1.5.3 Global Polymyxin B Market Average Price (2020-2031)

1.6 Assumptions and Limitations

2 Polymyxin B Market Competition by Manufacturers

2.1 Global Polymyxin B Sales Market Share by Manufacturers (2020-2025)

2.2 Global Polymyxin B Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Polymyxin B Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Polymyxin B, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Polymyxin B, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Polymyxin B, Product Type & Application

2.7 Global Key Manufacturers of Polymyxin B, Date of Enter into This Industry

2.8 Global Polymyxin B Market Competitive Situation and Trends

2.8.1 Global Polymyxin B Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Polymyxin B Players Market Share by Revenue

2.8.3 Global Polymyxin B Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Polymyxin B Market Scenario by Region

3.1 Global Polymyxin B Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Polymyxin B Sales by Region: 2020-2031

3.2.1 Global Polymyxin B Sales by Region: 2020-2025

3.2.2 Global Polymyxin B Sales by Region: 2026-2031

3.3 Global Polymyxin B Revenue by Region: 2020-2031

3.3.1 Global Polymyxin B Revenue by Region: 2020-2025

3.3.2 Global Polymyxin B Revenue by Region: 2026-2031

3.4 North America Polymyxin B Market Facts & Figures by Country

3.4.1 North America Polymyxin B Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Polymyxin B Sales by Country (2020-2031)

3.4.3 North America Polymyxin B Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Polymyxin B Market Facts & Figures by Country

3.5.1 Europe Polymyxin B Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Polymyxin B Sales by Country (2020-2031)

3.5.3 Europe Polymyxin B Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polymyxin B Market Facts & Figures by Region

3.6.1 Asia Pacific Polymyxin B Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Polymyxin B Sales by Region (2020-2031)

3.6.3 Asia Pacific Polymyxin B Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Polymyxin B Market Facts & Figures by Country

3.7.1 Latin America Polymyxin B Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Polymyxin B Sales by Country (2020-2031)

3.7.3 Latin America Polymyxin B Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Polymyxin B Market Facts & Figures by Country

3.8.1 Middle East and Africa Polymyxin B Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Polymyxin B Sales by Country (2020-2031)

3.8.3 Middle East and Africa Polymyxin B Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Polymyxin B Sales by Type (2020-2031)

4.1.1 Global Polymyxin B Sales by Type (2020-2025)

4.1.2 Global Polymyxin B Sales by Type (2026-2031)

4.1.3 Global Polymyxin B Sales Market Share by Type (2020-2031)

4.2 Global Polymyxin B Revenue by Type (2020-2031)

4.2.1 Global Polymyxin B Revenue by Type (2020-2025)

4.2.2 Global Polymyxin B Revenue by Type (2026-2031)

4.2.3 Global Polymyxin B Revenue Market Share by Type (2020-2031)

4.3 Global Polymyxin B Price by Type (2020-2031)

5 Segment by Application

5.1 Global Polymyxin B Sales by Application (2020-2031)

5.1.1 Global Polymyxin B Sales by Application (2020-2025)

5.1.2 Global Polymyxin B Sales by Application (2026-2031)

5.1.3 Global Polymyxin B Sales Market Share by Application (2020-2031)

5.2 Global Polymyxin B Revenue by Application (2020-2031)

5.2.1 Global Polymyxin B Revenue by Application (2020-2025)

5.2.2 Global Polymyxin B Revenue by Application (2026-2031)

5.2.3 Global Polymyxin B Revenue Market Share by Application (2020-2031)

5.3 Global Polymyxin B Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Polymyxin B Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Zhejiang Hisun Pharmaceutical

6.2.1 Zhejiang Hisun Pharmaceutical Company Information

6.2.2 Zhejiang Hisun Pharmaceutical Description and Business Overview

6.2.3 Zhejiang Hisun Pharmaceutical Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Zhejiang Hisun Pharmaceutical Polymyxin B Product Portfolio

6.2.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates

6.3 Xellia Pharmaceuticals

6.3.1 Xellia Pharmaceuticals Company Information

6.3.2 Xellia Pharmaceuticals Description and Business Overview

6.3.3 Xellia Pharmaceuticals Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Xellia Pharmaceuticals Polymyxin B Product Portfolio

6.3.5 Xellia Pharmaceuticals Recent Developments/Updates

6.4 Cipla

6.4.1 Cipla Company Information

6.4.2 Cipla Description and Business Overview

6.4.3 Cipla Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cipla Polymyxin B Product Portfolio

6.4.5 Cipla Recent Developments/Updates

6.5 Lupin

6.5.1 Lupin Company Information

6.5.2 Lupin Description and Business Overview

6.5.3 Lupin Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lupin Polymyxin B Product Portfolio

6.5.5 Lupin Recent Developments/Updates

6.6 B. Braun

6.6.1 B. Braun Company Information

6.6.2 B. Braun Description and Business Overview

6.6.3 B. Braun Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.6.4 B. Braun Polymyxin B Product Portfolio

6.6.5 B. Braun Recent Developments/Updates

6.7 Shanghai Pharmaceutical

6.7.1 Shanghai Pharmaceutical Company Information

6.7.2 Shanghai Pharmaceutical Description and Business Overview

6.7.3 Shanghai Pharmaceutical Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Shanghai Pharmaceutical Polymyxin B Product Portfolio

6.7.5 Shanghai Pharmaceutical Recent Developments/Updates

6.8 Novartis Sandoz

6.8.1 Novartis Sandoz Company Information

6.8.2 Novartis Sandoz Description and Business Overview

6.8.3 Novartis Sandoz Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novartis Sandoz Polymyxin B Product Portfolio

6.8.5 Novartis Sandoz Recent Developments/Updates

6.9 Alkem Labs

6.9.1 Alkem Labs Company Information

6.9.2 Alkem Labs Description and Business Overview

6.9.3 Alkem Labs Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Alkem Labs Polymyxin B Product Portfolio

6.9.5 Alkem Labs Recent Developments/Updates

6.10 Par Pharmaceutical

6.10.1 Par Pharmaceutical Company Information

6.10.2 Par Pharmaceutical Description and Business Overview

6.10.3 Par Pharmaceutical Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Par Pharmaceutical Polymyxin B Product Portfolio

6.10.5 Par Pharmaceutical Recent Developments/Updates

6.11 Gland Pharma

6.11.1 Gland Pharma Company Information

6.11.2 Gland Pharma Description and Business Overview

6.11.3 Gland Pharma Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Gland Pharma Polymyxin B Product Portfolio

6.11.5 Gland Pharma Recent Developments/Updates

6.12 Hikma

6.12.1 Hikma Company Information

6.12.2 Hikma Description and Business Overview

6.12.3 Hikma Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Hikma Polymyxin B Product Portfolio

6.12.5 Hikma Recent Developments/Updates

6.13 Merck

6.13.1 Merck Company Information

6.13.2 Merck Description and Business Overview

6.13.3 Merck Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Merck Polymyxin B Product Portfolio

6.13.5 Merck Recent Developments/Updates

6.14 Fresenius Kabi

6.14.1 Fresenius Kabi Company Information

6.14.2 Fresenius Kabi Description and Business Overview

6.14.3 Fresenius Kabi Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Fresenius Kabi Polymyxin B Product Portfolio

6.14.5 Fresenius Kabi Recent Developments/Updates

6.15 Hanmi Pharma

6.15.1 Hanmi Pharma Company Information

6.15.2 Hanmi Pharma Description and Business Overview

6.15.3 Hanmi Pharma Polymyxin B Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Hanmi Pharma Polymyxin B Product Portfolio

6.15.5 Hanmi Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polymyxin B Industry Chain Analysis

7.2 Polymyxin B Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polymyxin B Production Mode & Process Analysis

7.4 Polymyxin B Sales and Marketing

7.4.1 Polymyxin B Sales Channels

7.4.2 Polymyxin B Distributors

7.5 Polymyxin B Customer Analysis

8 Polymyxin B Market Dynamics

8.1 Polymyxin B Industry Trends

8.2 Polymyxin B Market Drivers

8.3 Polymyxin B Market Challenges

8.4 Polymyxin B Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Zhejiang Hisun Pharmaceutical

Xellia Pharmaceuticals

Cipla Ltd

Lupin Ltd

B. Braun

Shanghai Pharmaceutical

List of Tables

Table 1. Global Polymyxin B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Polymyxin B Market Value by Source, (US$ Million) & (2024 VS 2031)

Table 3. Global Polymyxin B Market Value by Application (2024 VS 2031) & (US$ Million)

Table 4. Global Polymyxin B Market Competitive Situation by Manufacturers in 2024

Table 5. Global Polymyxin B Sales (Kilotons) of Key Manufacturers (2020-2025)

Table 6. Global Polymyxin B Sales Market Share by Manufacturers (2020-2025)

Table 7. Global Polymyxin B Revenue (US$ Million) by Manufacturers (2020-2025)

Table 8. Global Polymyxin B Revenue Share by Manufacturers (2020-2025)

Table 9. Global Market Polymyxin B Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 10. Global Key Players of Polymyxin B, Industry Ranking, 2022 VS 2023 VS 2024

Table 11. Global Key Manufacturers of Polymyxin B, Manufacturing Sites & Headquarters

Table 12. Global Key Manufacturers of Polymyxin B, Product Type & Application

Table 13. Global Key Manufacturers of Polymyxin B, Date of Enter into This Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Polymyxin B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxin B as of 2024)

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Polymyxin B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Polymyxin B Sales by Region (2020-2025) & (Kilotons)

Table 19. Global Polymyxin B Sales Market Share by Region (2020-2025)

Table 20. Global Polymyxin B Sales by Region (2026-2031) & (Kilotons)

Table 21. Global Polymyxin B Sales Market Share by Region (2026-2031)

Table 22. Global Polymyxin B Revenue by Region (2020-2025) & (US$ Million)

Table 23. Global Polymyxin B Revenue Market Share by Region (2020-2025)

Table 24. Global Polymyxin B Revenue by Region (2026-2031) & (US$ Million)

Table 25. Global Polymyxin B Revenue Market Share by Region (2026-2031)

Table 26. North America Polymyxin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 27. North America Polymyxin B Sales by Country (2020-2025) & (Kilotons)

Table 28. North America Polymyxin B Sales by Country (2026-2031) & (Kilotons)

Table 29. North America Polymyxin B Revenue by Country (2020-2025) & (US$ Million)

Table 30. North America Polymyxin B Revenue by Country (2026-2031) & (US$ Million)

Table 31. Europe Polymyxin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 32. Europe Polymyxin B Sales by Country (2020-2025) & (Kilotons)

Table 33. Europe Polymyxin B Sales by Country (2026-2031) & (Kilotons)

Table 34. Europe Polymyxin B Revenue by Country (2020-2025) & (US$ Million)

Table 35. Europe Polymyxin B Revenue by Country (2026-2031) & (US$ Million)

Table 36. Asia Pacific Polymyxin B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 37. Asia Pacific Polymyxin B Sales by Region (2020-2025) & (Kilotons)

Table 38. Asia Pacific Polymyxin B Sales by Region (2026-2031) & (Kilotons)

Table 39. Asia Pacific Polymyxin B Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia Pacific Polymyxin B Revenue by Region (2026-2031) & (US$ Million)

Table 41. Latin America Polymyxin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 42. Latin America Polymyxin B Sales by Country (2020-2025) & (Kilotons)

Table 43. Latin America Polymyxin B Sales by Country (2026-2031) & (Kilotons)

Table 44. Latin America Polymyxin B Revenue by Country (2020-2025) & (US$ Million)

Table 45. Latin America Polymyxin B Revenue by Country (2026-2031) & (US$ Million)

Table 46. Middle East and Africa Polymyxin B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. Middle East and Africa Polymyxin B Sales by Country (2020-2025) & (Kilotons)

Table 48. Middle East and Africa Polymyxin B Sales by Country (2026-2031) & (Kilotons)

Table 49. Middle East and Africa Polymyxin B Revenue by Country (2020-2025) & (US$ Million)

Table 50. Middle East and Africa Polymyxin B Revenue by Country (2026-2031) & (US$ Million)

Table 51. Global Polymyxin B Sales (Kilotons) by Type (2020-2025)

Table 52. Global Polymyxin B Sales (Kilotons) by Type (2026-2031)

Table 53. Global Polymyxin B Sales Market Share by Type (2020-2025)

Table 54. Global Polymyxin B Sales Market Share by Type (2026-2031)

Table 55. Global Polymyxin B Revenue (US$ Million) by Type (2020-2025)

Table 56. Global Polymyxin B Revenue (US$ Million) by Type (2026-2031)

Table 57. Global Polymyxin B Revenue Market Share by Type (2020-2025)

Table 58. Global Polymyxin B Revenue Market Share by Type (2026-2031)

Table 59. Global Polymyxin B Price (US$/Ton) by Type (2020-2025)

Table 60. Global Polymyxin B Price (US$/Ton) by Type (2026-2031)

Table 61. Global Polymyxin B Sales (Kilotons) by Application (2020-2025)

Table 62. Global Polymyxin B Sales (Kilotons) by Application (2026-2031)

Table 63. Global Polymyxin B Sales Market Share by Application (2020-2025)

Table 64. Global Polymyxin B Sales Market Share by Application (2026-2031)

Table 65. Global Polymyxin B Revenue (US$ Million) by Application (2020-2025)

Table 66. Global Polymyxin B Revenue (US$ Million) by Application (2026-2031)

Table 67. Global Polymyxin B Revenue Market Share by Application (2020-2025)

Table 68. Global Polymyxin B Revenue Market Share by Application (2026-2031)

Table 69. Global Polymyxin B Price (US$/Ton) by Application (2020-2025)

Table 70. Global Polymyxin B Price (US$/Ton) by Application (2026-2031)

Table 71. Pfizer Company Information

Table 72. Pfizer Description and Business Overview

Table 73. Pfizer Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 74. Pfizer Polymyxin B Product

Table 75. Pfizer Recent Developments/Updates

Table 76. Zhejiang Hisun Pharmaceutical Company Information

Table 77. Zhejiang Hisun Pharmaceutical Description and Business Overview

Table 78. Zhejiang Hisun Pharmaceutical Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 79. Zhejiang Hisun Pharmaceutical Polymyxin B Product

Table 80. Zhejiang Hisun Pharmaceutical Recent Developments/Updates

Table 81. Xellia Pharmaceuticals Company Information

Table 82. Xellia Pharmaceuticals Description and Business Overview

Table 83. Xellia Pharmaceuticals Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Xellia Pharmaceuticals Polymyxin B Product

Table 85. Xellia Pharmaceuticals Recent Developments/Updates

Table 86. Cipla Company Information

Table 87. Cipla Description and Business Overview

Table 88. Cipla Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 89. Cipla Polymyxin B Product

Table 90. Cipla Recent Developments/Updates

Table 91. Lupin Company Information

Table 92. Lupin Description and Business Overview

Table 93. Lupin Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 94. Lupin Polymyxin B Product

Table 95. Lupin Recent Developments/Updates

Table 96. B. Braun Company Information

Table 97. B. Braun Description and Business Overview

Table 98. B. Braun Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 99. B. Braun Polymyxin B Product

Table 100. B. Braun Recent Developments/Updates

Table 101. Shanghai Pharmaceutical Company Information

Table 102. Shanghai Pharmaceutical Description and Business Overview

Table 103. Shanghai Pharmaceutical Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 104. Shanghai Pharmaceutical Polymyxin B Product

Table 105. Shanghai Pharmaceutical Recent Developments/Updates

Table 106. Novartis Sandoz Company Information

Table 107. Novartis Sandoz Description and Business Overview

Table 108. Novartis Sandoz Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 109. Novartis Sandoz Polymyxin B Product

Table 110. Novartis Sandoz Recent Developments/Updates

Table 111. Alkem Labs Company Information

Table 112. Alkem Labs Description and Business Overview

Table 113. Alkem Labs Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 114. Alkem Labs Polymyxin B Product

Table 115. Alkem Labs Recent Developments/Updates

Table 116. Par Pharmaceutical Company Information

Table 117. Par Pharmaceutical Description and Business Overview

Table 118. Par Pharmaceutical Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 119. Par Pharmaceutical Polymyxin B Product

Table 120. Par Pharmaceutical Recent Developments/Updates

Table 121. Gland Pharma Company Information

Table 122. Gland Pharma Description and Business Overview

Table 123. Gland Pharma Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 124. Gland Pharma Polymyxin B Product

Table 125. Gland Pharma Recent Developments/Updates

Table 126. Hikma Company Information

Table 127. Hikma Description and Business Overview

Table 128. Hikma Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 129. Hikma Polymyxin B Product

Table 130. Hikma Recent Developments/Updates

Table 131. Merck Company Information

Table 132. Merck Description and Business Overview

Table 133. Merck Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 134. Merck Polymyxin B Product

Table 135. Merck Recent Developments/Updates

Table 136. Fresenius Kabi Company Information

Table 137. Fresenius Kabi Description and Business Overview

Table 138. Fresenius Kabi Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 139. Fresenius Kabi Polymyxin B Product

Table 140. Fresenius Kabi Recent Developments/Updates

Table 141. Hanmi Pharma Company Information

Table 142. Hanmi Pharma Description and Business Overview

Table 143. Hanmi Pharma Polymyxin B Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 144. Hanmi Pharma Polymyxin B Product

Table 145. Hanmi Pharma Recent Developments/Updates

Table 146. Key Raw Materials Lists

Table 147. Raw Materials Key Suppliers Lists

Table 148. Polymyxin B Distributors List

Table 149. Polymyxin B Customers List

Table 150. Polymyxin B Market Trends

Table 151. Polymyxin B Market Drivers

Table 152. Polymyxin B Market Challenges

Table 153. Polymyxin B Market Restraints

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

Table 157. Authors List of This Report

List of Figures

Figure 1. Product Picture of Polymyxin B

Figure 2. Global Polymyxin B Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Polymyxin B Market Share by Type: 2024 & 2031

Figure 4. Injection Polymyxins Product Picture

Figure 5. Oral Polymyxins Product Picture

Figure 6. Topical Polymyxins Product Picture

Figure 7. Global Polymyxin B Market Value by Source, (US$ Million) & (2020-2031)

Figure 8. Global Polymyxin B Market Share by Source: 2024 VS 2031

Figure 9. Natural Fermentation Polymyxin B Product Picture

Figure 10. Semi-Synthetic Polymyxin B Product Picture

Figure 11. Purified Fermentation Polymyxin B Product Picture

Figure 12. Global Polymyxin B Market Value by Application (2020-2031) & (US$ Million)

Figure 13. Global Polymyxin B Market Share by Application: 2024 & 2031

Figure 14. Intestinal Disease

Figure 15. Infection

Figure 16. Septicemia

Figure 17. Peritonitis

Figure 18. Others

Figure 19. Global Polymyxin B Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Polymyxin B Market Size (2020-2031) & (US$ Million)

Figure 21. Global Polymyxin B Sales (2020-2031) & (Kilotons)

Figure 22. Global Polymyxin B Average Price (US$/Ton) & (2020-2031)

Figure 23. Polymyxin B Report Years Considered

Figure 24. Polymyxin B Sales Share by Manufacturers in 2024

Figure 25. Global Polymyxin B Revenue Share by Manufacturers in 2024

Figure 26. Global 5 and 10 Largest Polymyxin B Players: Market Share by Revenue in Polymyxin B in 2024

Figure 27. Polymyxin B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 28. Global Polymyxin B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 29. North America Polymyxin B Sales Market Share by Country (2020-2031)

Figure 30. North America Polymyxin B Revenue Market Share by Country (2020-2031)

Figure 31. United States Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Canada Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Europe Polymyxin B Sales Market Share by Country (2020-2031)

Figure 34. Europe Polymyxin B Revenue Market Share by Country (2020-2031)

Figure 35. Germany Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. France Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. U.K. Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Italy Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Russia Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Asia Pacific Polymyxin B Sales Market Share by Region (2020-2031)

Figure 41. Asia Pacific Polymyxin B Revenue Market Share by Region (2020-2031)

Figure 42. China Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Japan Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. South Korea Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. India Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Australia Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. China Taiwan Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Polymyxin B Sales Market Share by Country (2020-2031)

Figure 50. Latin America Polymyxin B Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Colombia Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Middle East and Africa Polymyxin B Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Polymyxin B Revenue Market Share by Country (2020-2031)

Figure 57. Turkey Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. UAE Polymyxin B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Global Sales Market Share of Polymyxin B by Type (2020-2031)

Figure 61. Global Revenue Market Share of Polymyxin B by Type (2020-2031)

Figure 62. Global Polymyxin B Price (US$/Ton) by Type (2020-2031)

Figure 63. Global Sales Market Share of Polymyxin B by Application (2020-2031)

Figure 64. Global Revenue Market Share of Polymyxin B by Application (2020-2031)

Figure 65. Global Polymyxin B Price (US$/Ton) by Application (2020-2031)

Figure 66. Polymyxin B Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions